Another reason for the raise is that, if fully subscribed, it gives RAC the option of paying for a $8m trial which was already planned but not yet funded, namely the pivotal EMD AML in the EU.
Ann: AGM Presentations, page-58
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
-0.085(4.56%) |
Mkt cap ! $315.0M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.86 | $1.78 | $246.9K | 135.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1042 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 9158 | 2 |
View Market Depth
| Last trade - 14.22pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.78 |
Change
-0.085 ( 5.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.81 | $1.86 | $1.76 | 18279 | ||
| Last updated 14.43pm 14/06/2024 ? | |||||
| RAC (ASX) Chart |